Multimodal image-guided surgery of HER2-positive breast cancer using [111In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor model

被引：0
|
作者：
Marion M. Deken
Desirée L. Bos
Willemieke S. F. J. Tummers
Taryn L. March
Cornelis J. H. van de Velde
Mark Rijpkema
Alexander L. Vahrmeijer
机构：
[1] Leiden University Medical Center,Department of Surgery
[2] Radboud University Medical Center,Department of Radiology and Nuclear Medicine
[3] Leiden University Medical Center,Department of Clinical Pharmacy and Toxicology
来源：
EJNMMI Research | / 9卷
关键词：
Multimodal imaging; HER2-positive breast cancer; [; In]In-DTPA-trastuzumab-IRDye800CW; Fluorescence; Image-guided surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Tumor infiltrating lymphocytes (TILs) indicate trastuzumab benefit in early-stage HER2-positive breast cancer (HER2+BC)
    Loi, S.
    Michiels, S.
    Salgado, R.
    Sirtaine, N.
    Jose, V.
    Fumagalli, D.
    Brown, D. N.
    Kellokumpu-Lehtinen, P-L
    Bono, P.
    Kataja, V.
    Desmedt, C.
    Piccart-Gebhart, M. J.
    Loibl, S.
    Untch, M.
    Denkert, C.
    Smyth, M. J.
    Joensuu, H.
    Sotiriou, C.
    CANCER RESEARCH, 2013, 73
  • [42] Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastases
    Okita, Yoshiko
    Narita, Yoshitaka
    Suzuki, Tsuyoshi
    Arita, Hideyuki
    Yonemori, Kan
    Kinoshita, Takayuki
    Fujiwara, Yasuhiro
    Tsuda, Hitoshi
    Komoike, Yoshifumi
    Nakagawa, Hidemitsu
    Tamaki, Yasuhiro
    Tomita, Yasuhiko
    Shibui, Soichiro
    Maruno, Motohiko
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (06) : 995 - 1001
  • [43] Depth of Response and Early Tumor Shrinkage for Predicting Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab
    Che, Yi-Qun
    Zhang, Yue
    Ou, Kai-Ping
    Wang, Di
    Shen, Di
    Liu, Hui-Ying
    Luo, Yang
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 8527 - 8534
  • [44] Streptavidin (SA)-trastuzumab (Tmab) Fab for linking biotinylated (Bi) multi-chelating site polymers (MCPs) for amplifying the delivery of 111In to HER2-positive breast cancer cells
    Boyle, Amanda
    Liu, Peng
    Lu, Yijie
    Weinrich, Dirk
    Winnik, Mitchell
    Reilly, Raymond
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [45] Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab
    Fujita, Noriko
    Enomoto, Yukie
    Inakami, Keiko
    Yanagisawa, Tetsu
    Iguchi, Chikage
    Aono, Toyokazu
    Nomura, Takashi
    Yamamoto, Hitoshi
    Kasugai, Tsutomu
    Shiba, Eiichi
    ONCOLOGY, 2020, 98 (01) : 35 - 41
  • [46] Combination of Near-Infrared Photoimmunotherapy Using Trastuzumab and Small Protein Mimetic for HER2-Positive Breast Cancer
    Yamaguchi, Haruka
    On, Jotaro
    Morita, Takao
    Suzuki, Takamasa
    Okada, Yasuo
    Ono, Junya
    Evdokiou, Andreas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [47] Metastatic brain tumors respond favorably to pyrotinib in a HER2-positive breast cancer following failure using trastuzumab
    Yao, Jing-Hao
    Xie, Zong-Yu
    Li, Man
    Zhang, Ming-Liang
    Ci, Hong-Fei
    Yang, Yan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (09): : 5874 - 5881
  • [48] Internalization-Responsive Poly(lactic-co-glycolic acid) Nanoparticles for Image-Guided Photodynamic Therapy against HER2-Positive Breast Cancer
    Sogomonyan, Anna S.
    Deyev, Sergey M.
    Shipunova, Victoria O.
    ACS APPLIED NANO MATERIALS, 2023, 6 (13) : 11402 - 11415
  • [49] Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer
    Baselga, Jose
    Phillips, Gail D. Lewis
    Verma, Sunil
    Ro, Jungsil
    Huober, Jens
    Guardino, Alice E.
    Samant, Meghna K.
    Olsen, Steve
    de Haas, Sanne L.
    Pegram, Mark D.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3755 - 3763
  • [50] Anthracycline followed by trastuzumab is still one of treatment options for small tumor with node-negative HER2-positive breast cancer
    Akiyoshi, S.
    Kobayashi, K.
    Kobayashi, T.
    Hosonaga, M.
    Kitagawa, D.
    Ito, T.
    Ueno, T.
    Ohno, S.
    BREAST, 2019, 44 : S20 - S21
12345